NEPHROGENEX, INC. (NRXGQ) financial statements (2020 and earlier)

Company profile

Business Address 3200 BEECHLEAF COURT
RALEIGH, NC 27604
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2229
Cash and cash equivalents1914
Short-term investments315
Restricted cash and investments0 
Other undisclosed current assets10
Total current assets:2329
Noncurrent Assets
Property, plant and equipment00
Other noncurrent assets00
Total noncurrent assets:00
TOTAL ASSETS:2329
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities33
Accounts payable22
Accrued liabilities00
Employee-related liabilities11
Debt20
Other undisclosed current liabilities20
Total current liabilities:83
Noncurrent Liabilities
Long-term debt and lease obligation46
Long-term debt, excluding current maturities46
Liabilities, other than long-term debt00
Other liabilities00
Total noncurrent liabilities:46
Total liabilities:1210
Stockholders' equity
Stockholders' equity attributable to parent1119
Common stock00
Additional paid in capital9277
Accumulated other comprehensive loss(0)(0)
Accumulated deficit(81)(58)
Total stockholders' equity:1119
TOTAL LIABILITIES AND EQUITY:2329

Income statement (P&L) ($ in millions)

12/31/2015
12/31/2014
Operating expenses(22)(17)
Operating loss:(22)(17)
Nonoperating income
(Investment Income, Nonoperating)
00
Interest and debt expense(1)(0)
Net loss:(23)(17)
Other undisclosed net loss attributable to parent (0)
Net loss available to common stockholders, diluted:(23)(17)

Comprehensive Income ($ in millions)

12/31/2015
12/31/2014
Net loss:(23)(17)
Comprehensive loss:(23)(17)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)
Comprehensive loss, net of tax, attributable to parent:(23)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: